RESEARCHER PROFILE

Manar Mohammed El Tabaa

University of Sadat City

MicroRNA in disease regulationCancer-related molecular mechanisms researchNeuroinflammation and Neurodegeneration MechanismsMedicinal Plants and NeuroprotectionEffects and risks of endocrine disrupting chemicals

Manar Mohammed El Tabaa works in MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Neuroinflammation and Neurodegeneration Mechanisms, Medicinal Plants and Neuroprotection, Effects and risks of endocrine disrupting chemicals. Recorded institutional associations include Tanta University, University of Sadat City, Al-Farahidi University.

46Publications

458Citations

13H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

← Return to the university profile

Manar Mohammed El Tabaa

University of Sadat City

Selected research works

Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost

Suppressing NLRP3 activation and PI3K/AKT/mTOR signaling ameliorates amiodarone-induced pulmonary fibrosis in rats: a possible protective role of nobiletin

Neuroprotective role of Ginkgo biloba against cognitive deficits associated with Bisphenol A exposure: An animal model study

GLP-1 mediates the neuroprotective action of crocin against cigarette smoking-induced cognitive disorders via suppressing HMGB1-RAGE/TLR4-NF-κB pathway

Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma

Dapagliflozin mitigates ovalbumin-prompted airway inflammatory-oxidative successions and associated bronchospasm in a rat model of allergic asthma

Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma

Silymarin constrains diacetyl-prompted oxidative stress and neuroinflammation in rats: involvements of Dyn/GDNF and MAPK signaling pathway

Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson’s disease

Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of oral cancer

Harmine alleviated STZ-induced rat diabetic nephropathy: A potential role via regulating AMPK/Nrf2 pathway and deactivating ataxia-telangiectasia mutated (ATM) signaling

New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19

Emerging insights: miRNA modulation of ferroptosis pathways in lung cancer

miRNAs as modulators of neuroinflammation and excitotoxicity: Implications for stroke therapeutics

The PPAR-α agonist oleoyethanolamide (OEA) ameliorates valproic acid-induced steatohepatitis in rats via suppressing Wnt3a/β-catenin and activating PGC-1α: Involvement of network pharmacology and molecular docking

Does ( −)-epigallocatechin-3-gallate protect the neurotoxicity induced by bisphenol A in vivo?

Unraveling the impact of miRNAs on gouty arthritis: diagnostic significance and therapeutic opportunities

Protective effects of Kaempferol on hepatic apoptosis via miR-26a-5p enhancement and regulation of TLR4/NF-κB and PKCδ in a rat model of nonalcoholic fatty liver

Reduced NF-κB/NLRP3/IL-18 signaling increases the protective effect of L-glutamine against LPS-induced retinal inflammation in mice: Utilization of network pharmacology and experimental validation

SERCA2a directs the cardioprotective role of nano-emulsion curcumin against PM2.5-induced cardiac injury in rats by prohibiting PERK-eIF2α pathway

Crocin Modulates AKT / mTORC1 / ULK1 Cascade to Attenuate Ferritinophagy‐Induced Colonic Oxidative Injury in Ulcerative Colitis: Network Pharmacology, Molecular Docking, and Experimental Validation

The emerging role of miRNAs in pituitary adenomas: From molecular signatures to diagnostic potential

Natural compounds as modulators of miRNAs: a new frontier in bladder cancer treatment

miRNAs in Erdheim‐Chester Disease: A Paradigm of Multisystem Histiocytosis

Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057]